维普中文期刊产品整合服务
48篇 您的检索式:作者名="Robson JE"
    题名 作者 年代 出处 被引量
1Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-con- cept trlal显示文摘Tutt A Robson M C arber JE 2010Lancet2010,376,9737:1
2Oral poly(ADP-ribose) polymer- ase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial 显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
3Oral poly(ADP-ribose) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘Tutt A Robson M Garber JE 2010Lan- cet2010,376,9737:1
4Oral poly(ADP-ri- bose) polymerase inhibitor olaparib in patients with BRCAI or BRCA2 mutations and advanced breast can- cer: a proof-of-concept trial显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
5Oral poly ( ADP-ribose ) poly- merase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast cancer: a proof-of-concept trial 显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
6Imprinted noncoding RNAs显示文摘Peters J Robson JE 2008Mamm Genome2008,19,78:1
7Oral poly(ADP-ribose)pol- ymerase inhibitor olaparib in patients with BRCA1 or BRCA2 muta- tions and advanced breast caneer:a proof of concept trial显示文摘Tutt A Robson M Garber JE et ai 2010Lan- cet2010,376,9737:1
8Oral poly (ADP-ribose)polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘Tutt A Robson M Garber JE 0,,:1
9Effects of high-dose modi-fied-release nicotinic acid on atherosclerosis and vascular function:a randomized,placebo-controlled,magnetic resonance imaging study显示文摘Lee JM Robson MD Yu LM Shirodaria CC CunningtonC Kylintireas I Digby JE Bannister T Handa A Wiesmann F Durrington PN Channon KM Neubauer S Choudhury RP 2009J Am Coll Cardiol2009,54,19:1
10'Phase Ⅱ trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer'显示文摘Tutt A Robson M Garber JE 2009J Clin Oncol2009,27,:1
11Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCAI or BRCA2 mutations and advanced breast cancer :a proof-of-concept trial 显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
12Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proofof-concept trial显示文摘Tutt A Robson M Garber JE 0,,9737:1
13Oral poly (ADP- ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof- of- concept trial显示文摘TUTT A ROBSON M GARBER JE et ol 2010Lallo_t2010,376,9737:1
14Greating safer and healthier workplaces:role of organizational factors and job characteristics 显示文摘Shannon HS Robson LS Sale JE 2001Am J Ind Med2001,40,3:1
15Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘Tutt A Robson M Garber JE 0,,9737:1
16Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
17Phase Ⅱ trial of the oral PARP inhibitor olaparib in BRCA -deficient advanced breast cancer显示文摘Tutt A Robson M Garber JE 2009J Clin Oncol (Meeting Abstracts)2009,18,:1
18Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial 显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
19PhaseⅡtrial of the oralPARP inhibitor olaparib in BRCA-deficient advanced breastcancer显示文摘Tutt A Robson M Garber JE 2009J Clin Oneol(Meeting Abstracts)2009,27,:1
20Oral poly(ADP-ribose)polymerase inhibitor olaparib in patients with BRCA1 orBRCA2 mutations and advanced breast cancer:a proof-of-concept trial显示文摘Tutt A Robson M Garber JE 2010Lancet2010,376,9737:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费